2019 PDA Pharmaceutical Product Quality Testing Conference

2019 PDA Pharmaceutical Product Quality Testing Conference
A recent article in the PDA Letter (1) argued that the pharmaceutical industry should stop using the ubiquitous dye ingress test. The authors of this response would like to present an alternative view—that the industry should not limit its testing options if those extensively used and accepted methods are still useful and appropriate tools for ensuring patient safety